Editorial: Translating NK cell scientific research to clinical product manufacturing

Front Immunol. 2023 Aug 23:14:1229417. doi: 10.3389/fimmu.2023.1229417. eCollection 2023.

Evelyn Ullrich^{1

2

3}, Volker Huppert⁴, Torsten Tonn⁵, Wing Leung⁶

¹ Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University Frankfurt, Frankfurt, Germany.
² Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany.
³ German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany.
⁴ Glycostem Therapeutics B.V., Oss, Netherlands.
⁵ Transfusion Medicine, Medical Faculty Carl Gustav Carus, TU Dresden and Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, Dresden, Germany.
⁶ Department of Pediatrics, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.

No abstract available

Keywords: ATMP; NK cells; Natural Killer cells; cell therapy; good manufacturing practice (GMP); manufacturing; tumor therapy.

Publication types